“We find little compelling evidence to suggest that [legalization] result in increases in illicit drug use, arrests for part I offenses, drug-involved overdoses, or drug-related treatment admissions for addiction.”
Investigators concluded, “These analyses do not demonstrate an association between marijuana use and an increased risk of early-onset ischemic stroke.”
Subjects showed improved cognitive performance within three months of treatment and that these improvements were sustained for one year.
Opioid-related hospitalizations fell nearly eight percent among males during the first six-months following the enactment of legalization laws.
Researchers reported, “[These] results failed to support our hypothesis that concentrates would exacerbate cognitive impairments.”
The study’s findings “suggest that using CBD as a strategy to alleviate withdrawal symptoms upon nicotine cessation may be beneficial.”
The Senate Leader said: "I will use my clout as Majority Leader to make this [legislation] a priority in the Senate. … It makes eminent sense to legalize marijuana."
Investigators concluded, "In summary, we find no evidence to support the presumption that cannabis consumption leads to a decline in neurocognitive ability."